Cutaneous Allodynia and Its Risk Factors in Korean Patients with Migraine: A Survey of Two Tertiary Care Hospitals

Aims: To measure the prevalence of cutaneous allodynia in Korean patients with migraine and to characterize the differential risks of migraine-associated factors and psychiatric disorders in its development. Methods: The study included consecutive patients with migraine who visited headache clinics at two tertiary care hospitals. Questionnaires including the 12-item Allodynia Symptom Checklist (ASC-12) and the Migraine Disability Assessment (MIDAS) were administered to the patients. The Mini International Neuropsychiatric Interview-Plus, Version 5.0.0 (MINI), was performed to diagnose current major depressive disorder (MDD) and current generalized anxiety disorder (GAD). To determine the predictive factors of cutaneous allodynia, a two-step logistic regression model was used. Results: A total of 332 patients were eligible for the study. Chronic migraine (CM) was present in 140 patients (42.2%). Current MDD and current GAD were identified in 73 (21.9%) and 59 patients (17.7%), respectively. Cutaneous allodynia was present in 48 patients (14.5%). Univariate analyses indicated that cutaneous allodynia was associated with female gender, CM, medication overuse headache, headache intensity, photophobia, phonophobia, MIDAS grade, current MDD, and current GAD. Multivariate analyses revealed that current MDD was the strongest risk factor for cutaneous allodynia (adjusted odds ratio [AOR] = 4.552; 95% confidence intervals [CI] = 2.300–9.007; P = .000), followed by CM (AOR = 3.666; 95% CI = 1.787–7.521; P = .000) and photophobia (AOR = 2.707; 95% CI = 1.340–5.469; P = .005). Conclusion: Korean patients with migraine have a low prevalence of cutaneous allodynia. Both depression and migraine-associated features are important factors in the occurrence of cutaneous allodynia.

allodynia; depression; frequency; migraine; risk factor

1. Mersky H, Bogduk N, International Association for the Study of Pain Task Force on Taxonomy. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: IASP, 1994.

2. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614–624.

3. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008;63:148–158.

4. Louter MA, Bosker JE, van Oosterhout WP, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain 2013; 136:3489–3496.

5. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: A race against the developmentof central sensitization. Ann Neurol 2004;55:27–36.

6. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: A race against the development of cutaneous allodynia. Ann Neurol 2004;55:19–26.

7. Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: A population study. Neurology 2008;70:1525–1533.

8. Tietjen GE, Brandes JL, Peterlin BL, et al. Allodynia in migraine: Association with comorbid pain conditions. Headache 2009;49:1333–1344.

9. Louter MA, Wardenaar KJ, Veen G, et al. Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia 2014;34:1187–1192.

10. Chou CH, Fuh JL, Wu JC, Wang SJ. Comparison of self-reported cutaneous allodynia and brushing allodynia during migraine attacks. Cephalalgia 2010;30:682–685.

11. Kao CH, Wang SJ, Tsai CF, Chen SP, Wang YF, Fuh JL. Psychiatric comorbidities in allodynic migraineurs. Cephalalgia 2014;34:211–218.

12. Schwier C, Kliem A, Boettger MK, Bär KJ. Increased cold-pain thresholds in major depression. J Pain 2010;11:287–290.

13. Zusman M. Forebrain-mediated sensitization of central pain pathways: ‘Non-specific’ pain and a new image for MT. Man Ther 2002;7:80–88.

14. Shi M, Qi WJ, Gao G, Wang JY, Luo F. Increased thermal and mechanical nociceptive thresholds in rats with depressive-like behaviors. Brain Res 2010;1353:225–233.

15. Kundermann B, Hemmeter-Spernal J, Strate P, et al. Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine. J Psychiatr Res 2009;43:1253–1261.

16. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33: 629–808.

17. Lee HS, Chung CS, Song HJ, Park HS. The reliability and validity of the MIDAS (Migraine Disability Assessment) Questionnaire for Korean migraine sufferers. J Korean Neurol Assoc 2000; 18:287–291.

18. Yoo SW, Kim YS, Noh JS, et al. Validity of Korean version of the MINI international neuropsychiatric interview. Anxiety Mood 2006;2:50–55.

19. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 (suppl 20):22–33.

20. Maizels M, Smitherman TA, Penzien DB. A review of screening tools for psychiatric comorbidity in headache patients. Headache 2006;46(suppl 3):S98–S109.

21. Kim SY, Park SP. Suicidal ideation and risk factors in Korean migraine patients. J Clin Neurosci 2014;21:1699–1704.

22. Roh JK, Kim JS, Ahn YO. Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache 1998;38:356–365.

23. Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache 2001;41:629–637.

24. Nagakura Y, Oe T, Aoki T, Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain 2009;146:26–33.

25. Noseda R, Kainz V, Jakubowski M, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci 2010;13:239–245.

26. Pascual J, Colás R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001;5:529–536.